ライフサイエンスコーパス: glycoconjugate

1 from rabbits immunized with a trisaccharide glycoconjugate.

2 t H. ducreyi may express a putative ECA-like glycoconjugate.

3 ommon germline precursor when presented as a glycoconjugate.

4 lipids and proteins on their surface, called glycoconjugates.

5 e for the synthesis of biologically relevant glycoconjugates.

6 r the fragmentation of peptide backbones and glycoconjugates.

7 lex undertaking that requires access to pure glycoconjugates.

8 ilability and enhances desialylation of host glycoconjugates.

9 pon dehalogenation gave C-2 deoxy amino acid glycoconjugates.

10 as modular building blocks for more complex glycoconjugates.

11 els in glucose-containing polysaccharides or glycoconjugates.

12 e protein toward beta1-galactosyl-terminated glycoconjugates.

13 oval of sialic acid residues from sialylated glycoconjugates.

14 , yielding 'multicopy-multivalent' nanoscale glycoconjugates.

15 interacting with beta1-galactosyl-terminated glycoconjugates.

16 an affinity for beta-galactoside containing glycoconjugates.

17 allenge for glycobiology and the analysis of glycoconjugates.

18 nition sites on the cell surface or secreted glycoconjugates.

19 yse the removal of terminal sialic acid from glycoconjugates.

20 in order to provide monodisperse multivalent glycoconjugates.

21 ng end of the bulk of cell surface-expressed glycoconjugates.

22 upon microbiota, including growth-promoting glycoconjugates.

23 properties and protein binding functions of glycoconjugates.

24 c acids are essential components of membrane glycoconjugates.

25 known to be caused by impaired synthesis of glycoconjugates.

26 al modifications on the trafficking of these glycoconjugates.

27 are used to assemble other bacterial surface glycoconjugates.

28 de hydrolases of dietary polysaccharides and glycoconjugates.

29 al analysis to characterize goblet cell muco-glycoconjugates.

30 inant gp120, Candida albicans, and synthetic glycoconjugates.

31 the synthesis of these biologically relevant glycoconjugates.

32 nules through interactions with cell-surface glycoconjugates.

33 otocrosslinker into sialic acids in cellular glycoconjugates.

34 y be a rational approach for improving other glycoconjugates.

35 ur in di- and polysaccharides, as well as in glycoconjugates.

36 shift with an altered array of cell surface glycoconjugates.

37 ty of PllA for alpha-galactoside-terminating glycoconjugates.

38 ith specific carbohydrate structures of MFGM glycoconjugates.

39 carbohydrate-centered and heteromultivalent glycoconjugates.

40 r conjugation to bovine serum albumin (BSA), glycoconjugates 1 to 6 were used to develop individual i

41 erse range of novel regioselective triazolyl glycoconjugates 6a-u have been achieved in high yields v

42 The glycoconjugate 8 displayed excellent affinity and select

43 S1 overexpressing tumors, the diarylpyrazole glycoconjugate 8, derived from the potent NTS1 antagonis

44 ace keratinization, epitheliopathy, and muco-glycoconjugate acidification.

45 -hexosaminidase with consequent clearance of glycoconjugates, alpha-synuclein and ubiquitinated prote

46 This glycoconjugate also elicits cytokine production from hum

47 hat dictates the solution behaviour of these glycoconjugates, although the lower intrinsic viscositie

48 tion strategy based on immunization with the glycoconjugate and the subsequent administration of an i

49 thogen that encounters terminally sialylated glycoconjugates and free sialic acid (Sia) in the airway

50 ction requires the presence of host core-1 O-glycoconjugates and is therefore carbohydrate-dependent.

51 nodeficiency virus by recognition of surface glycoconjugates and mediates their internalization into

52 quitous in biologically important classes of glycoconjugates and naturally occurring oligosaccharides

53 acid diester mediated coupling reactions for glycoconjugates and presents recent advances that aim to

54 osslinkers introduce a covalent bond between glycoconjugates and their binding partners, allowing phy

55 osynthetic pathway of nematode PC-containing glycoconjugates and, in particular, the identity of the

56 sed for characterising, imaging or targeting glycoconjugates and, when printed on microarrays, they a

57 e lungs, we found extensive desialylation of glycoconjugates, and upregulation of sialidases.

58 esized and conjugated to proteins to provide glycoconjugate antigens and conjugate vaccines.

59 nt synthesis methods of oligosaccharides and glycoconjugates are a requisite.

60 Glycoconjugates are composed of carbohydrate building bl

61 L-Fucose-containing glycoconjugates are essential for a myriad of physiologi

62 Synthetic oligosaccharides and glycoconjugates are increasingly used as probes for biol

63 These glycoconjugates are involved in host-cell interactions a

64 eoxy amino l-sugars present in the bacterial glycoconjugates are not available from natural sources.

65 Polysaccharides and glycoconjugates are not encoded directly by genes; inste

66 Our discovery of how glycoconjugates are processed resulting in presentation

67 tively, these results suggest that CPS-based glycoconjugates are promising candidates for the develop

68 g oligosaccharides, glycoproteins, and other glycoconjugates are providing access to critical materia

69 Cell surface glycoconjugates are used as markers for undifferentiated

70 r classes of biomolecules, carbohydrates and glycoconjugates are widely involved in numerous biologic

71 We also demonstrate a "carboassay" using glycoconjugates as capture and reporter elements, which

72 ggest that the shifting between the sulfated glycoconjugates as distinct targets of CTX A2, A3, and A

73 fic and concomitant interaction with the two glycoconjugates as well as on dynamic avidity effects ty

74 f commercially important polysaccharides and glycoconjugates as well.

75 for the preparation of oligosaccharides and glycoconjugates bearing the 1,2-cis-2-amino glycosidic l

76 otocol has been developed for easy access to glycoconjugate benzothiazoles from protected carbohydrat

77 nsorgrams provides robust information of the glycoconjugate binding efficiency and real-time structur

78 osamines, which are potential precursors for glycoconjugate biosynthesis.

79 e was assessed for a selected S. Typhimurium glycoconjugate by challenge with live Salmonella.

80 , it is now possible to generate tailor-made glycoconjugates by attaching polysaccharides derived fro

81 h direct engagement of specific cell surface glycoconjugates by traditional ligand-receptor binding.

82 . Typhimurium, we have synthesized different glycoconjugates, by linking O-antigen and core sugars (O

83 l versatility of glycan epitopes in cellular glycoconjugates calls for developing sensitive methods t

84 that glycosylation and thus the function of glycoconjugates can be regulated by a protein that helps

85 Measurement of concentrations of selected glycoconjugates can be used to screen for many of these

86 u5Gc), typically found at the distal ends of glycoconjugate chains at the cell surface.

87 ion of free mannose due to the processing of glycoconjugates composed of glucose-derived mannose and

88 The ability to control the glycoconjugate concentration in the membrane provides a

89 Glycoconjugates containing stable, monovalent synthetic

90 ormation has been available concerning their glycoconjugate content.

91 a family of glycosaminoglycan (GAG)-protein glycoconjugates, contribute to animal physiology through

92 nses against the OPS or CPS component of the glycoconjugates could be raised in BALB/c mice, only tho

93 can also be secreted to bind to cell surface glycoconjugate counterreceptors.

94 Experiments using a model glycoconjugate demonstrated that this O-glycosidase, tog

95 The formation of glycoconjugates depends on nucleotide sugars, which serv

96 The hydrophilic glycoconjugate derivative (12) showed improved inhibitio

97 uggests that DMAG may be an active cell wall glycoconjugate driving host-pathogen interactions and pa

98 obtaining the glycan's crystal structure in glycoconjugates due to its flexibility and heterogeneity

99 ation and on the obtention of lysine-glucose glycoconjugates during Maillard reaction (MR) has been s

100 To identify new approaches to enhancing glycoconjugate effectiveness, we investigated molecular

101 Terminal sialic acid residues of glycoconjugates exhibit remarkable functional and struct

102 acting glucose ligands, whereas the N-linked glycoconjugate exhibited binding kinetics consistent wit

103 atives, gangliosides, are the major class of glycoconjugates expressed by neurons.

104 s known about the regulation of autophagy by glycoconjugates focusing on signaling mechanisms from th

105 ogens' surface and use them to develop novel glycoconjugates for vaccine development.

106 ntensity ultrasound efficiently promotes BLG-glycoconjugates formation by MR in aqueous solutions und

107 ple, the accumulation of volatile phenols in glycoconjugate forms following grapevine exposure to bus

108 tigen Lewis X and Y epitopes, known to mimic glycoconjugates found on human tissues, was also affecte

109 hromatography (R-HPLC) to isolate and purify glycoconjugates from several natural sources.

110 By binding cell surface glycoconjugates, galectin-1 (gal-1) is involved in cell

111 cells per muL]) and received a 5 mug dose of glycoconjugate GBS vaccine (serotypes Ia, Ib, and III, w

112 l vaccination with an investigational CRM197-glycoconjugate GBS vaccine elicited higher GBS serotype-

113 mpare safety and immunogenicity of trivalent glycoconjugate GBS vaccine in pregnant women with and wi

114 This glycoconjugate generated titres of antibodies towards th

115 Glycoconjugates, glycans, carbohydrates, and sugars: the

116 the synthesis of therapeutically significant glycoconjugates (glycosaminoglycans, glycoproteins, glyc

117 Glycoconjugates had an approximately unimodal log-normal

118 Multivalent glycoconjugates have also been used for stimulating the

119 The capsule and other cellular glycans and glycoconjugates have been described, but the machinery r

120 Fucosylated oligosaccharides and glycoconjugates have been implicated in several biologic

121 Many multivalent glycoconjugates have therefore been synthesized to study

122 ent data suggest that one mechanism by which glycoconjugates impact physiology is through the regulat

123 y a water-organic solvent interface than its glycoconjugates, important for the formulation in polyme

124 nly influences the physical behaviour of the glycoconjugate in solution.

125 nd enables cell imaging and visualization of glycoconjugates in alkynyl-saccharide-treated cells at e

126 are important for the assembly of essential glycoconjugates in all domains of life.

127 nes (glycogenes) involved in biosynthesis of glycoconjugates in conjunctiva of normal subjects and pa

128 alcohol nucleophiles to provide the desired glycoconjugates in good yields with excellent alpha-sele

129 ing to a wide variety of alcohols to provide glycoconjugates in high yields with excellent levels of

130 tigating the roles of C. jejuni cell surface glycoconjugates in host pathogen interactions.

131 nrecognized accumulation of a diverse set of glycoconjugates in NPC1-null and NPC2-deficient fibrobla

132 se UGTs may add to the production of further glycoconjugates in planta.

133 method for the synthesis of C-2 deoxy-2-iodo glycoconjugates in self-assembled structures was found u

134 dy investigated the accumulation of guaiacol glycoconjugates in the fruit, shoots and leaves of Monas

135 oth unexpectedly resulted in accumulation of glycoconjugates in the Golgi apparatus rather than in th

136 studies demonstrate that the distribution of glycoconjugates in the membrane leaflet can be controlle

137 activated capsular polysaccharides and their glycoconjugates - in the form most relevant to their pot

138 These glycoconjugates include tumor-associated carbohydrate an

139 A series of cyclodextrin-based glycoconjugates, including glycoclusters and star glycop

140 dies have indicated a role for nonsialylated glycoconjugates, including histo-blood group antigens (H

141 (M6P) is an essential precursor for mannosyl glycoconjugates, including lipid-linked oligosaccharides

142 ranose (Galf)-containing polysaccharides and glycoconjugates, including O-glycans, N-glycans, fungal-

143 , which when combined produce diastereomeric glycoconjugates indistinguishable by mass spectrometry.

144 mediate opsonophagocytic killing, the other glycoconjugates induced effective opsonic antibodies, wi

145 ing relocation in the heptamer and (ii) that glycoconjugates inhibited VCC by promoting its assembly

146 Thus, this semi-synthetic glycoconjugate is a lead for the development of a vaccin

147 detection of the carbohydrate components of glycoconjugates is critical for advancing glycobiology.

148 regarding the glycan structure of protonated glycoconjugates is hindered by the inability to differen

149 Dysregulation in biosynthesis of sialo-glycoconjugates is known to be associated with neurologi

150 and sialic acid, a major component of airway glycoconjugates, is identified as the host-derived metab

151 cleavage of terminal sialic acids from host glycoconjugates, is involved in both of these processes.

152 elease of terminal sialic acid residues from glycoconjugates, is involved in host colonization in ani

153 he biosynthetic precursor of Galf-containing glycoconjugates, is produced from UDP-galactopyranose (U

154 ith affinity for beta-galactoside-containing glycoconjugates, is upregulated upon infection, and it h

155 sequent injection with cyclooctyne reagents, glycoconjugate labeling was observed on isolated splenoc

156 fluenzae type b (Hib), and the corresponding glycoconjugate made by conjugating this with the tetanus

157 and action mechanisms via distinct sulfated glycoconjugate-mediated processes.

158 ed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vac

159 N. lactamica is even more potent than after glycoconjugate meningococcal vaccination.

160 nsferases as tools for in vitro synthesis of glycoconjugate mimics with clinical significance.

161 ynthesis of a number of clinically important glycoconjugate mimics.

162 the concise synthesis of naturally occurring glycoconjugate motifs containing N-acetylgalactosamine (

163 in fusion proteins to sialic acid-containing glycoconjugates, observed in enzyme-linked immunosorbent

164 ns revealed that binding of the two types of glycoconjugates occurs within different binding sites.

165 ne (3a-3x), 2-spiroquinazolinone (5, 7), and glycoconjugates of 2,3-dihydroquinazolin-4(1H)-one (10a,

166 cessfully used for labeling azido-containing glycoconjugates of living cells.

167 The biosynthesis of the major cell envelope glycoconjugates of Mycobacterium tuberculosis is topolog

168 ose (Galf) residues are present in cell wall glycoconjugates of numerous pathogenic microbes.

169 In this study, we use glycoconjugates of type 3 Streptococcus pneumoniae CPS (

170 osyl residues for mannosyl residues into the glycoconjugates of worms and mammals.

171 Fucose is a sugar present in glycoconjugates often associated with recognition and ad

172 bing the galectin-induced multimerization of glycoconjugates on cultured cells.

173 mediated by lectins (adhesins) that bind to glycoconjugates on the surface of host cells.

174 Sialylated glycoconjugates on the surfaces of mammalian cells play

175 ha-GalNAc epitope and cross-link low valency glycoconjugates, only SBA showed a tendency to form inte

176 Indeed, carbohydrates and glycoconjugates play a major role in key biological even

177 Surface glycoconjugates play important roles in the infectious c

178 tereochemical isomers present in glycans and glycoconjugates poses a formidable challenge for compreh

179 e zeroth order with respect to the amount of glycoconjugate present at the bilayer was observed.

180 HBGAs are genetically determined glycoconjugates present in mucosal secretions, epithelia

181 We have analyzed the structure of this glycoconjugate, previously described to contain the suga

182 design and synthesis of a panel of 24 novel glycoconjugate primary sulfonamides that bind to the ext

183 independent microwells in which 64 spots of glycoconjugates probes are arrayed by using DNA Directed

184 hondroitin sulfate (CS) over other potential glycoconjugate products.

185 fter grapevine treatment; however, different glycoconjugate profiles were apparent.

186 In this work, glycoconjugate prototypes were prepared by coupling S. s

187 of the TM was reduced, as was the content of glycoconjugates reacting with the lectin wheat germ aggl

188 dissect the mechanisms that underlie altered glycoconjugate recycling and storage in disease.

189 Glycoconjugates regulate a variety of biological events

190 These reagents were applied to reveal the glycoconjugates regulating human myeloid cell adhesion t

191 gical potential as these enzymes can produce glycoconjugates relevant to the pharmaceutical industry.

192 The uniquely modified glycoconjugates represent valuable tools for investigati

193 The addition of Sia to glycoconjugates requires metabolic activation to CMP-Sia

194 s spectrometry, to quantify guaiacol and its glycoconjugates, respectively.

195 nization with the synthetic hexasaccharide 1 glycoconjugate resulted in high titers of cross-reactive

196 strate that deglycosylation of a human serum glycoconjugate(s) by the combined effects of NanA, BgaA,

197 display aberrant surface glycans and related glycoconjugate scaffolds.

198 High molecular weight glycoconjugate secretion was measured with an enzyme-lin

199 s a cAMP-dependent increase in [Ca(2+)]i and glycoconjugate secretion, but not ERK1/2 activation.

200 .5 mug, 5.0 mug, or 20 mug) of each of three glycoconjugates (serotypes Ia, Ib and III).

201 of 0.5, 2.5, or 5.0 mug of each of 3 CRM197-glycoconjugates (serotypes Ia, Ib, and III), or placebo.

202 The glycoconjugates showed >/=94% residual enzyme activity a

203 These glycoconjugates showed high affinity binding to the huma

204 novo sequencing of purified plant metabolite glycoconjugates, showing that the anomeric signature is

205 volved in the sorting of galactoside-bearing glycoconjugates, since it was found associated with the

206 etic glycopolymers enable the integration of glycoconjugate structural and spatial diversity in a sin

207 Subsequently, we investigated glycoconjugate structure, activity, and stability.

208 resent on their surfaces natural multivalent glycoconjugates such as lipopolysaccharides and S-layers

209 es miscellaneous applications of oxime-based glycoconjugates, such as enantioselective catalysis and

210 ply may also be important for nucleotide and glycoconjugate syntheses in the insect host.

211 s a simple, flexible biocatalytic method for glycoconjugate synthesis using PglB N-glycosylation mach

212 tomized native chemical ligation concept for glycoconjugates synthesis, utilizing a meticulously cont

213 Sperm-ZP binding was largely inhibited by glycoconjugates terminated with sialyl-Lewis(x) sequence

214 ite Trichomonas vaginalis contains a surface glycoconjugate that appears to mediate parasite-host cel

215 Here, we report the synthesis of a glycoconjugate that displays the so-called 'inner core'

216 The amazing repertoire of glycoconjugates that are found in Campylobacter jejuni i

217 rabinomannan (LAM) are key Corynebacterineae glycoconjugates that are integral components of the myco

218 ly on the availability of chemically defined glycoconjugates that can be selectively modified under o

219 may enhance turnover of N-cadherin and other glycoconjugates that determine junctional stability and

220 cus on glycosphingolipids (GSLs), a class of glycoconjugates that is challenging to study, recognized

221 urfaces of bacteria are replete with diverse glycoconjugates that play pivotal roles in determining h

222 gands comprise a heterogeneous collection of glycoconjugates that share related glycan structures but

223 porter strategy for labeling of cell surface glycoconjugates that takes advantage of recombinant glyc

224 A key component of this structure is a glycoconjugate, the mycolyl-arabinogalactan-peptidoglyca

225 phylactic use and, in combination with Le(b) glycoconjugates, therapeutic use in treatment of drug-re

226 S. pneumoniae cleaves sialic acid from human glycoconjugates to be used as a carbohydrate source.

227 acteria that must secrete proteins and large glycoconjugates to grow, divide, and persist.

228 However, progress toward complex glycoconjugate total synthesis has been slowed by the ne

229 molecules, mimicking mammalian cell surface glycoconjugates triggering autoimmune responses.

230 Transient interactions among glycoconjugates underlie developmental, immunological an

231 tructure prediction/modeling of N-glycans of glycoconjugates using structure database could be effect

232 gitidis serogroup C monovalent meningococcal glycoconjugate vaccine (MenC) (at 2 and 4 months).

233 development of a candidate O-antigen-CRM197 glycoconjugate vaccine against S. Typhimurium.

234 idly, following the recent introduction of a glycoconjugate vaccine against serogroup A.

235 ously described a mechanism by which a model glycoconjugate vaccine can activate the adaptive immune

236 In conclusion, an O-antigen-CRM197 glycoconjugate vaccine can induce O-antigen-specific ant

237 ied this system to the characterization of a glycoconjugate vaccine candidate consisting of a genetic

238 -->2)-beta-mannans and to the viability of a glycoconjugate vaccine composed of a minimal length olig

239 y of all polysaccharides of a multicomponent glycoconjugate vaccine CRM197-MenACWY.

240 late CD4(+) T cells has key implications for glycoconjugate vaccine design that could result in great

241 vaccine similar to that which occurs with a glycoconjugate vaccine despite a less robust reduction i

242 a meningococcal tetravalent (serogroup ACWY) glycoconjugate vaccine is recommended for all US adolesc

243 umoniae Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antig

244 chieved with other encapsulated pathogens, a glycoconjugate vaccine strategy was selected to elicit o

245 An archetypical glycoconjugate vaccine that we constructed to maximize t

246 rst steps toward identifying components of a glycoconjugate vaccine to prevent E. faecium infection.

247 erning the immune response to a prototypical glycoconjugate vaccine.

248 on with the serogroup C meningococcal (MenC) glycoconjugate vaccine.

249 These glycoconjugate vaccines (GBSIII-OVA and GBSIII-TT) are s

250 that differences in the design of OAg-based glycoconjugate vaccines against invasive African S. Typh

251 Here, we report the development of candidate glycoconjugate vaccines against MenX and preclinical dat

252 findings support the further development of glycoconjugate vaccines against MenX and their assessmen

253 operties which may affect the performance of glycoconjugate vaccines against serious disease are mola

254 Pneumococcal glycoconjugate vaccines are expensive and provide limite

255 Although glycoconjugate vaccines are generally very efficacious,

256 Glycoconjugate vaccines based on isolated capsular polys

257 Glycoconjugate vaccines based on synthetic oligosacchari

258 The sequential use of two distinct glycoconjugate vaccines containing the same polysacchari

259 Highly effective glycoconjugate vaccines exist against four of the five m

260 rotection against infection; therefore, O-PS glycoconjugate vaccines have proven useful against a num

261 Glycoconjugate vaccines have provided enormous health be

262 n shown to potentiate the immune response to glycoconjugate vaccines in humans, we investigated if Al

263 However, the distribution of effective glycoconjugate vaccines in this region is limited by the

264 ents a proof of concept for the potential of glycoconjugate vaccines in veterinary medicine applicati

265 Glycoconjugate vaccines provide a safe and reliable stra

266 ors of long term humoral immunity induced by glycoconjugate vaccines received in early infancy.

267 a manual polysaccharide assay applicable for glycoconjugate vaccines such as Prevenar to an automated

268 o prepare, purify and characterize two model glycoconjugate vaccines that can be used to generate Tca

269 ibe an alternative methodology for producing glycoconjugate vaccines whereby recombinant O-PS biosynt

270 Glycoconjugate vaccines, consisting of an antigenic carr

271 ride epitopes can aid in the design of novel glycoconjugate vaccines.

272 ion of CPSs with carrier proteins to produce glycoconjugate vaccines.

273 signation 'Tcarbs') after stimulation by two glycoconjugate vaccines.

274 mulation of the immune system by alternative glycoconjugate vaccines.

275 such as bacterial or viral glycoproteins or glycoconjugate vaccines.

276 support the use of Alum-TLR7 as adjuvant for glycoconjugate vaccines.

277 Functionality of the Cyt c glycoconjugates was determined by performing cell-free c

278 blet cell secretion of high molecular weight glycoconjugates was measured by an enzyme-linked lectin

279 Caspase 9 activation by the glycoconjugates was with 92 +/- 7% to 96 +/- 4% within t

280 All glycoconjugates were compared for immunogenicity and abi

281 Guaiacol glycoconjugates were observed in fruit and leaves in par

282 Solubility and emulsifying properties of glycoconjugates were significantly improved as compared

283 Different glycoconjugates were synthesized by coupling MenX oligos

284 Five neo-glycoconjugates were synthesized, Lac4-Cyt-c, Lac9-Cyt-c

285 he CRM197 carrier protein, and the resulting glycoconjugates were used to immunize rabbits.

286 but also the GLUT1 specificity of resulting glycoconjugates, where GLUT1 is glucose transporter 1.

287 ling intra- and extracellular azido-modified glycoconjugates, whereas S-DIBO 8 cannot pass the cell m

288 s concept and are devising a plethora of neo-glycoconjugates which can interfere with a series of pat

289 --> 2)-S-linked thiosaccharides and S-linked glycoconjugates, which are difficult to synthesize by cl

290 y responses against the CPS component of the glycoconjugate, while immunization with Hcp1 and TssM pr

291 A series of glycoconjugates with defined connectivity were synthesiz

292 t glucals and rhamnals into disaccharides or glycoconjugates with high alpha-selectivity and yields (

293 e the simulation system and input of various glycoconjugates with most sugar types and chemical modif

294 Dilignol glycoconjugates with reduced structures were found in th

295 and K(d) values provided similar ranking for glycoconjugates with respect to PA-IL binding thus affor

296 zing the removal of Neu5Ac from a variety of glycoconjugates with retention of configuration at the a

297 surface carbohydrates as well as of soluble glycoconjugates with their receptor proteins rule fundam

298 zine, allowing for the imaging of sialylated glycoconjugates within live zebrafish embryos.

299 iffusion by direct interaction with specific glycoconjugates within the adherens junction.

300 study of the dynamic changes occurring among glycoconjugates within the cellular compartments.